# Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda

> **NCT05323721** · PHASE4 · UNKNOWN · sponsor: **Malaria Consortium** · enrollment: 6805 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Sulfadoxine pyrimethamine and amodiaquine
- **DRUG:** dihydroartemisinin-piperaquine

## Key facts

- **NCT ID:** NCT05323721
- **Lead sponsor:** Malaria Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 6805 (ACTUAL)
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05323721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05323721, "Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05323721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*